SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-22-011313
Filing Date
2022-03-09
Accepted
2022-03-09 16:11:38
Documents
6
Effectiveness Date
2022-03-09

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea156646-s8_protaratherap.htm S-8 57309
2 OPINION OF COOLEY LLP ea156646ex5-1_protaratherap.htm EX-5.1 7563
3 CONSENT OF MARCUM LLP ea156646ex23-1_protaratherap.htm EX-23.1 2164
4 CONSENT OF ERNST & YOUNG LLP ea156646ex23-2_protaratherap.htm EX-23.2 2124
5 FILING FEE TABLE ea156646ex-fee_protaratherap.htm EX-FILING FEES 19292
6 GRAPHIC ex5-1_001.jpg GRAPHIC 16752
  Complete submission text file 0001213900-22-011313.txt   112872
Mailing Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010 646-844-0337
Protara Therapeutics, Inc. (Filer) CIK: 0001359931 (see all company filings)

IRS No.: 204580525 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-263392 | Film No.: 22725501
SIC: 2836 Biological Products, (No Diagnostic Substances)